chrisvoncsefalvay/vaers-outcomes huggingface dataset:
In the evening after my second vaccine dose, my ears began aching and tinnitus started. Over the next couple days the ear aches slowly away, but the tinnitus has persisted.
On day 8, circular red rash at injection site. Swelling and itching at injection site. Swollen lymph node in right side of neck.
Swollen area around the spot of vacination size 2.5 inches length wise/ wide by 1 inch high or long ways
Sandpaper-like, diffuse, papular rash on front of both thighs up to groin area, above knees.
Fatigue & Sleepiness on the afternoon of 8/30/19  On Morning of 9/1/19, tingling of feet, lower legs & hands (as well as itching)  On Afternoon of 9/1/19, difficulty breathing, gasping for air, decreased lung capacity, Pt went to ER following these symptoms
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination. No Medical History information was reported. On 24-Nov-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 24-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.The Moderna vial was removed from freezer to refrigerator on 24 NOV 2021. Concomitant and treatment medication was not reported.
15 mins after dose tongue swelled, stopped after 20 mins  3 hours later, extreme fatigue, chills, tingling in fingers and toes, pressure on brain.  Only chills stopped. Other symptoms still remain.   5 hours later.  Threw up and diarrhea. Pain in heart area which has still not subsided.   48 hours later: difficulty breathing starts.
This spontaneous report was received from a Registered Nurse refers to a 3 month old patient of an unknown gender. The patient's pertinent medical history, concurrent conditions and drug reactions/allergies were not provided. On 01-MAR-2018, the patient was vaccinated with improperly stored LIQUID PEDVAXHIB, lot # N012921 (expiry date: 28-FEB-2020) for prophylaxis (incorrect product storage). The vaccine was concomitantly reconstituted with properly stored sterile diluent (MERCK). The vaccine underwent a temperature excursion of 34.70 F for 0.25 hours. No adverse effects were reported. The call was because of a data logger. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1804USA000815: US-009507513-1809USA002917: US-009507513-1809USA002918: US-009507513-1809USA002919: US-009507513-1809USA002920: US-009507513-1809USA002921: US-009507513-1809USA002922: US-009507513-1809USA002923.
Patient received vaccine dose around 13:20. At approx. 13:25 patient began to audibly wheeze, became pale, diaphoretic, and had mild circumoral swelling. Patient received 0.3 mg  epinephrine via EpiPen at 13:26, and 911 was called.  Patient lost consciousness at 13:27 and pt was lowered to floor from chair to prevent a fall. Patient immediately regained consciousness. Patient was transferred to a chair and vitals were obtained at 1330. BP 112/60, HR 86, SPO2 96% on rom air. Mild wheezes bilaterally over anterior bronchi, all other breath sounds clear throughout. EMS arrived, patient was still slightly pale and was transported to ED. Upon leaving, patient was AOx4, ambulatory, and without respiratory distress.  Per ER note, patient was given Benadryl and solumedrol by EMS.   At the ER, patient received NS bolus 1L, and Benadryl 25 mg orally. Patient was medically cleared by ED MD to go home at 17:58 pm on 5/21/21
Per patient, a few days after receiving vaccine, noticed swelling, on 9/8/2011 boil developed and burst 09/12/2011.
Extreme fatigue & chills starting on day 5 after vaccine.  Chills no longer present but fatigue & extreme sleepiness still present today 4/14/21, 9 days later.  I was previously infected with Covid 19 in 9/2020 with a positive igG & igM antibody test in 12/20.
dose of PNEUMOV AX 23 was administered to a patient after a temperature excursion; No AE; Information has been received from a medical assistant, referring to a patient of unknown gender, who was currently 24 years old. The patient's medical history, concurrent conditions and concomitant therapies were not reported.   On an unknown date, the patient was vaccinated with an improperly stored dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) lot # T027110 and expiration date 23-MAR-2022 (administration route and anatomical location were not provided) for prophylaxis. No adverse effects were reported.   The vaccine had a temperature excursions of 32.9 Fahrenheit (F) during a time frame of 24 hours. It was confirmed that no previous temperature excursions occurred.
I received my third Moderna dose (booster) on December 15th. On December 16th, I experienced high fever, body aches and lethargy. On December 17th, I felt fine again. On December 24th, I began to experience itchy hives in various places over my body (back of head, neck, waist and behind the knees). This has continued until today (December 26th), as well as new body aches and lethargy.
Red rash localized around the site of injection.  Rash is warm to the touch. Patient also claims to have achiness.
no adverse effects; unspecified number of unspecified patients have been administered doses of improperly stored vaccines; This spontaneous report was received from a nurse and refers to an unspecified  patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical histories provided.  On 25-MAR-2020, the patient was vaccinated with improperly stored doses of  measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) lot # S030206 with expiration date of 25-MAR-2021(upon internal validation),0 .5 milliliter, subcutaneous in the left thigh for prophylaxis and diphtheria toxoid, pertussis acellular 3-component vaccine, poliovirus vaccine inactivated (vero), tetanus toxoid(KINRIX). No adverse event was reported.  This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-2003USA002275:Original Case : 2003USA002275 US-009507513-2008USA008883:Original Case : 2003USA002275 US-009507513-2008USA008876:Original Case : 2003USA002275 US-009507513-2008USA008875:Original Case : 2003USA002275 US-009507513-2008USA008877:Original Case : 2003USA002275 US-009507513-2008USA008878:Original Case : 2003USA002275 US-009507513-2008USA008879:Original Case : 2003USA002275 US-009507513-2008USA008880:Original Case : 2003USA002275 US-009507513-2008USA008881:Original Case : 2003USA002275 US-009507513-2008USA008884:Original Case : 2003USA002275 US-009507513-2008USA008886:Original Case : 2003USA002275 US-009507513-2008USA008887:Original Case : 2003USA002275 US-009507513-2008USA008889:Original Case : 2003USA002275 US-009507513-2008USA008889:Original Case : 2003USA002275 US-009507513-2008USA008890:Original Case : 2003USA002275 US-009507513-2008USA008891:Original Case : 2003USA002275 US-009507513-2008USA008892:Original Case : 2003USA002275 US-009507513-2008USA008893: US-009507513-2008USA008894: US-009507513-2008USA008895: US-009507513-2008USA008896: US-009507513-2008USA008897: US-009507513-2008USA008898: US-009507513-2008USA008899: US-009507513-2008USA008900: US-009507513-2008USA008901: US-009507513-2008USA008902: US-009507513-2008USA008903: US-009507513-2008USA008904: US-009507513-2008USA008905: US-009507513-2008USA008906: US-009507513-2008USA008907: US-009507513-2008USA008908: US-009507513-2008USA008909: US-009507513-2008USA008910: US-009507513-2008USA008911: US-009507513-2008USA008912: US-009507513-2008USA008913: US-009507513-2008USA008914: US-009507513-2008USA008915: US-009507513-2008USA008916: US-009507513-2008USA008917: US-009507513-2008USA008918: US-009507513-2008USA008919: US-009507513-2008USA008920: US-009507513-2008USA008921: US-009507513-2008USA008922: US-009507513-2008USA008923: US-009507513-2008USA008924: US-009507513-2008USA008925: US-009507513-2008USA008926: US-009507513-2008USA008927: US-009507513-2008USA008928: US-009507513-2008USA008929: US-009507513-2008USA008930: US-009507513-2008USA008931: US-009507513-2008USA008932: US-009507513-2008USA008933:
Fever, chills, nausea, vomiting , stomach pain, no energy for 4 days. Eight days later still lack of energy and painful, itchy and rash at vaccine site.
Systemic: Dizziness / Light headiness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Hypotension-Severe, Additional Details: Patient was given the 1st dose of the Pfizer COVID vaccine around 4:50pm PST without incident and she was directed to wait for 15 minutes in the store. the pharmacy technician monitoring patients noticed around 4:57pm that patient was pale and slumped over in her chair & alerted me. Immediately, patient fainted while seated, into arms. 911 was alerted & they came 10 mins afterwards. EMS found her BP to be low and recommended she go to the ER, but she refused.
I have chronic lung issues; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), . The reporter is the patient.  A patient (no qualifiers provided) received pneumococcal 13-val conj vac (dipht CRM197 protein) (PREVNAR 13), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: CHRONIC RESPIRATORY DISEASE (non-serious), outcome "unknown", described as "I have chronic lung issues".  Additional information: Description of Event Outcome: I had Prevnar 13 years ago. I have chronic lung issues can I receive Prevnar 20  Follow-up attempts are completed. No further information is expected.
Death R41.82 - Altered mental status N39.0 - Urinary tract infection N17.9 - Acute kidney injury (CMS/HCC) A41.9 - Sepsis (CMS/HCC)
Information has been received regarding a case in litigation concerning a female child who resides with her father that was injected with vaccinations containing the mercury-based preservative thimerosal. The pt received "at least 3 shots" of Heptavax, Engerix and Recombivax vaccinations from 8/95 to 2/96. The pt displayed symptoms of neurological damage soon after the 1st vaccination. It was reported that the pt's eyes became crossed, started flapping her hands, stared into space, hearing became hypersensitive, had tightness in her feet and experienced loss of muscle tone. It was noted that the pt never developed language skills. The pt was receiving Chelation Therapy and had received approx. 300 Hyperbaric Oxygen therapy treatments. It was also noted that the pt was taking sulphur pills 3 days a week to "pull the mercury out of her system". The alleged result of these vaccinations is that the pt suffers from and in the future will continue to suffer from diminution in earning capacity, ability to enjoy life and to live independently, establishment and maintenance of personal relationships and in the usual and normal activities of daily living due to the toxic neurological effects of mercury poisoning. Upon internal review, mercury poisoning, neurological disorder, eyes became crossed, started flapping her hands, stared into space, hearing became hypersensitive, had tightness in her feet, experienced loss of muscle tone and never developed language skills were considered to be "Other Important Medical Events". No further information is available.
Since 04/01/21 I have headache, joint pain ,  weakness ,  dizzines , chills and had fever for  2- 3 days after second   vaccination .
I had fatigue, headache, and low-grade fever. I have sore throat and lost of voice. I have these symptoms over a week now. I went to the doctor for a Covid-19 test, positive result. They also did a Flu test, negative result.
Client received injection at 08:35 on 12/13/00; called nurse at 08:50 complaining of rash all over, pink on face, pinpoint spots on arms, stomach and chest red. Also complaining of itchiness. Improving. Referred to MD for ? Rx and to check rash. Denies temperature.
The vaccine was administered 6 days too early. The first dose was given on 1.6.22 and the second dose was given on 1.21.22. No adverse symPtoms were observed. Patient was observed for 45 minutes. Vital signs at 1701 BP 108/72, 95bPm, 99 % 16resPirations. Parents were instructed to seek emergency medical services for any signs or symPtoms and to call their Pediatrician immediately for monitoring.
got sick for 3 days; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got sick for 3 days) in a 62-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (got sick for 3 days). At the time of the report, ILLNESS (got sick for 3 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product was not provided by the reporter. Treatment information was not provided.
blew up my arm so bad/all hell broke loose; swollen arm; arm pain; This case was reported by a consumer via  interactive digital media and described the occurrence of arm discomfort in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (got the original shot years ago).   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced arm discomfort, swelling arm and pain in arm. The patient was treated with prednisone. On an unknown date, the outcome of the arm discomfort, swelling arm and pain in arm were unknown.   It was unknown if the reporter considered the arm discomfort, swelling arm and pain in arm to be related to Shingles vaccine.  Additional details provided were as follows: The reporter is the patient himself/herself. Age at vaccination was not reported. The patient got the original shot years ago and then they came out with the new one and he/she received it. The patient received the first part of the shot years and it blew up the arm so bad he/she had to take prednisone and other meds for a month. The patient also stated that he/she would not take the shot second time. The patient also felt hell broke loose, a real bad reaction, swollen arm and pain. The patient also received prednisone and a lot of medication for month. Follow-up would not be possible as no contact details available.
ChiLD GiVeN VAcciNE thAt MAY hAVe hAD teMperAtuRe EXCURsioN (Data LOGGeR FAilure) With stABle FriDGe teMps Before + After. Agency determine the VACCiNe to Be At RiSK + ADVISeD Reporting + ReVacciNAtion CHILD HAD NO ill Effects thus FAR
Describe Safety Event (factual and objective) Client received her first dose of the Pfizer vaccine and at the end of her 15 minute post-vaccination wait period in her car, she took off her mask and her husband noticed that her face appeared flushed. Client has a history of allergy to amoxicillin and propranolol as well as seasonal allergies. Vital signs were as follows: BP=155/88, Pulse=111. Client stated that that she did not feel itchy. She denied shortness of breath, difficulty breathing and a rash. Client verbalized that she felt fine, and would take an antihistamine once she arrived home. She was asked to call 911 if she experienced any symptoms such as trouble breathing or she noticed any rash. She voiced understanding and left with her husband.
Rash on face, chest, back, arms, legs. Erythematous slightly raised round spots 0.2-1 mm diam, no vesicles, papules, scale, or crust.
Warm, red,edema left arm shoulder down elbow 8/23/02, called clinic, no fever, sm amt cellulitis, Tx-Zithromax
After the patient had received the vaccine she was asked to stay in the store for 15 minutes per policy, Patient stepped away, and once returned she said she did not feel good. The staff sat her down and was asked if needed to call her ambulance. Patient Declined. She called her husband who then picked her up. Patient said she felt dizzy and light-headed. The staff also noticed that her pupils were really big and she had a slow speech. We still insisted to call an ambulance but patient wanted to be with her husband.
Loss of smell, painful lymph nodes in left armpit , painful bicep, painful achy joints in left arm all the way to fingers, swollen lymph nodes in throat, headache's.
03/27/22 presents to ED for "chest pain" "States he tested covid positive on home testing kit mid February.  Currently has no symptoms of Covid". PMHx of "CAD, DM, stent placement"
Right after the vaccine I had a metallic taste on my mouth it went away till midnight. Later on that day I also had lost of taste and smell that went away about 3 days later. I also experienced fatigue and a sever headache. My headache has not gone away. I contact my neurologist this morning and they will do an MRI on me they will call me back with my appointment information.
This spontaneous report was received from a physician, and the 59 year old female patient, referring to herself. The patient's medical history included; past drug reaction/allergy to ibuprofen. Concurrent conditions included; gastrooesophageal reflux disease (GERD), high blood pressure, high cholesterol and osteoporosis. Concomitant therapies included; amlodipine, ZETIA, ZOLOFT, gabapentin and ZOCOR. On 06-DEC-2012, the patient was vaccinated with ZOSTAVAX to prevent shingles (strength, dose, frequency, route of administration, lot number and expiration date were not reported). On the same date, the patient experienced a big bump where the shot was administered. The patient also reported, that her physician during consultation told her, that the swelling would go down, and was told to treat the swelling with ice. The patient also reported, that the swelling did not go down and had a hard bump like a callus in that area that was about 3 inches around, described by the physician as a swollen painful mass at the injection site. In 2013 or 2014 (no specific date was given), the patient still got the shingles (vaccination failure). On unknown date, the patient had a blood work test, however results were not provided. The outcome of vaccination failure, vaccination site pain, vaccination site swelling and vaccination site mass was not recovered. The outcome of the herpes zoster was not provided. At the time of the report, the causal relationship between the aforementioned events and ZOSTAVAX was not reported.
I have Shingles. Had the shingles vaccine and still contracted a severe  case of shingles.
Employee/patient reported symptoms starting on 03-16-2021 with a sore throat, which is now gone. Then went into body aches and low grade fever of 100.4. Now it is more nasal congestion, fatigue, runny nose and sneezing.
Immediate unusual taste in mouth, followed by headaches, fatigue, fever, breathlessness, weakness, unusual pain. Just found out my heart is enlarged.
fever 104, severe h/a. bloating all over, chest pains, difficulty breathing, throat, ear, eye pain, runny nose, painful joints, back pain, stomach pains, painful urination, lethragic, unable to get up & stand;
a red rash almost like a heat rash on upper torso; Initial information received on 12-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer(patient). This case involved a male patient who had a red rash almost like a heat rash on upper torso, while he received vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].   Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, around 10 am he received the vaccine. He noticed on Sunday and today that he had a red rash almost like a heat rash on upper torso (latency approximately 2 days).   Other relevant tests were not reported.  Final diagnosis was a red rash almost like a heat rash on upper torso.   It was not reported if the patient received a corrective treatment.  At the time of reporting, the event outcome was unknown.  There will be no information regarding batch number for this case.
I had chills, a fever, and extreme nausea for about 45 minutes to an hour. Then I went to bed. When I woke up the next morning, I felt completely fine.
Pt came in to get The Shringix vaccine and was given a first dose of phizer instead. Pt has already had 2 vaccines of moderna and did not request vax for Covid. ADMIN ERROR ON PHARMACY
Information has been received from a nurse concerning an 18 week old female who on 30-NOV-2007 was vaccinated with Hib conj vaccine (OMPC) (Lot #656517/0257U).  On approximately 30-NOV-2007 the patient developed a lump on her neck.  She was seen by an ENT for lymphadenitis.  On 06-DEC-2007 the patient was admitted to the hospital.  On 11-DEC-2007 she was discharged.  At the time of this report, the patient was recovering.  It was unknown which dose in the series this was for the patient.  Additional information has been requested.
Patient received vaccination midday on 4/30, had mild generalized myalgias on 5/1, by evening of 5/2 had generalized weakness of all extremities causing her to be unable to ambulate was found down on the floor. Admitted to the hospital on 5/1 and transferred to our medical center on 5/2 with persistent weakness.  Physical exam concerning for possible transverse myelitis versus myositis versus vaccine reaction with 4/5 strength in all 4 extremities
This spontaneous report was received from a certified medical assistant (C.M.A.) and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not specified. On 08-JAN-2016, the patient was vaccinated with an improperly stored dose of M-M-R II (rHA) (dose and route of administration were not provided) lot # L012479, expiry date 10-APR-2017. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.